Gaurav Kaul has been appointed Managing Director and Chief Executive Officer of Cipla Health, effective October 2026. He takes on the role after more than five years with Cipla.
Kaul most recently served as Chief Commercial Head – Rx, India Business, where he led Cipla’s India commercial operations across acute and chronic therapies. According to his profile, he was responsible for a business worth over ₹15,000 crore and an organisation of more than 12,000 employees.
Prior to this, Kaul was Chief Commercial Head – Respiratory at Cipla, where he led the category’s P&L. During his tenure, Cipla’s respiratory portfolio retained the top position in the Indian Pharmaceutical Market, while he also worked on patient-centric initiatives and consumer campaigns.
Kaul joined Cipla in 2021 following a career spanning consumer healthcare and sales. He spent nearly eight years with GSK Consumer Healthcare India, where he held leadership roles including General Manager – West and East and General Manager – Pharmacy. He also served as Head Sales for India and Sri Lanka at Novartis Consumer Healthcare.
Earlier, Kaul spent nearly five years with Cadbury, working across shopper and customer marketing as well as branch sales.
